The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials

Overview of attention for article published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews, March 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 5 news outlets
twitter: 6 X users

reddit: 1 Redditor

Readers on

mendeley: 56 Mendeley

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 100,905 followers.

@gregmushen Review of Amla supplementation showed a significant reduction in CRP (p = 0.002), fasting blood glucose (FBG) (p < 0.001), LDL-c) p < 0.001), total cholesterol (TC) (p < 0.001), and serum triglyceride (TG) (p < 0.001), HDL-c (p &…

@MohammedAlo @grandpawfloyd1 The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials https://t.co/lxS8zeFVp7

@itsajin Forget all links. Let's take a random one. https://t.co/qn2H1vgHBP - what separate safety study is needed?

@itsajin Can you explain what's missing? https://t.co/natZeqnmsZ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.